022 24172311
Sections
Search
DealCurry
Equity
Venture Capital
Private Equity
M&A

Banner
DataBoard Demo
Mergers & Acquisitions | 3 August 2012

Sun Pharma To Acquire German Drug Maker Stada

by Vivek Singh
Sun Pharma To Acquire German Drug Maker Stada
Share on Social Media Email Facebook Twitter Linkedin
 
@vivek

Sun Pharmaceutical is planning acquisitions in Europe and is in talks with German drug maker Stada Arzneimittel AG.

The overseas acquisition is a part of strategic move to broaden its geographic breadth. Sun Pharma has followed a strategy of acquiring under-performing or unprofitable companies and merging their operations to its company.

The company is planning to raise $1 Bn for the acquisitions as the market value of the German drug maker is around $1.7 Bn. Sun Pharma has about $927 Mn cash on its balance sheet.

Hero MotoCorp Invests In Erik Buell Racing of U.S

Hero MotoCorp Invests In Erik Buell Racing of U.S

Hero MotoCorp Limited invested $20 Mn in American racing company Erik Buell Racing (EBR).

Read More...

Druva raises $51m from Sequoia, EDBI and others

Druva raises $51m from Sequoia, EDBI and others

Sunnyvale, California-based Druva Inc., a cloud-first data protection solution provider, announced receiving $51 million in funding. This round of funding was led by existing investor Sequoia India, along with participation of new investors such as Blue Cloud Ventures, Hercules Capital, and Singapore-based EDBI. Existing investors like Japan’s NTT Finance (financial arm of Japanese telecommunications company Nippon Telegraph and Telephone Corporation), Nexus Venture Partners and Tenaya Capital also contributed to this round.

Read More...
Subscribe
Enter your Email address
to receive all the news